A Case Series and Literature Review of Telogen Effluvium and Alopecia Universalis after the Administration of a Heterologous COVID-19 Vaccine Scheme
Open Access
Abstract
COVID-19 vaccines have positively changed the course of the pandemic. They entered the market after only one year of the initial trials, which that yielded positive results in terms of safety and efficacy. However, after inoculating billions of people in the most extensive vaccination campaign worldwide, mild but common and some rare but potentially fatal adverse events have been reported. Among several self-reported adverse events, hair loss and alopecia have been linked to COVID-19 mRNA or viral vector vaccines. We tracked and followed a series of five cases with post-vaccine telogen effluvium and alopecia development in Ecuador. Here, we reported the clinical presentation of two women and three men with the diagnosis of post-vaccine hair loss. All patients received a heterologous vaccination scheme (mRNA and attenuated virus vaccine) with an additional viral vector booster associated with the apparition of telogen effluvium and alopecia universalis between 3 and 17 days after the vaccine was administered.Keywords
This publication has 30 references indexed in Scilit:
- Comorbidities in alopecia areata: A systematic review and meta-analysisJournal of the American Academy of Dermatology, 2019
- Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia AreataJAMA Dermatology, 2018
- Alopecia areataJournal of the American Academy of Dermatology, 2018
- Race and Alopecia Areata amongst US WomenJournal of Investigative Dermatology Symposium Proceedings, 2018
- Pulse corticosteroid therapy with oral dexamethasone for the treatment of adult alopecia totalis and universalisJournal of the American Academy of Dermatology, 2016
- Hepatitis C Treatment and Alopecia TotalisJournal of Investigative Dermatology Symposium Proceedings, 2013
- Type 1 interferon signature in the scalp lesions of alopecia areataBritish Journal of Dermatology, 2010
- Do we fully understand the economic value of vaccines?Vaccine, 2007
- A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLEArthritis Care & Research, 2007
- Hair Loss After Routine ImmunizationsJAMA, 1997